Reverse-remodeling after coronary artery bypass grafting in ischemic cardiomyopathy: assessment of myocardial viability by delayed-enhanced magnetic resonance imaging can help cardiac surgeons
- PMID: 17670732
- DOI: 10.1510/icvts.2007.155275
Reverse-remodeling after coronary artery bypass grafting in ischemic cardiomyopathy: assessment of myocardial viability by delayed-enhanced magnetic resonance imaging can help cardiac surgeons
Abstract
Preoperative delayed-enhanced magnetic resonance imaging (DE-MRI) was performed to estimate myocardial viability in a 57-year-old man with ischemic cardiomyopathy in order to decide the best course of treatment. The patient was diagnosed as having congestive heart failure with triple-vessel involvement (ejection fraction of 7%, end-diastolic volume index of 160 ml/m2, end-systolic volume index of 148 ml/m2). 99mTc-sestamibi single-photon emission computed tomography revealed severe reduction of the uptake at both stress and resting phases in the anterior, lateral and inferior segments. However, DE-MRI demonstrated transmural hyperenhancement to be <25% within the whole ventricular wall, implying that, though there was extensive subendoventricular myocardial infarction, there was substantial viable myocardium. Therefore, with the expectation that functional recovery was possible with coronary revascularization alone, we performed a complete revascularization with off-pump coronary artery bypass grafting. Six months after the operation, catheterization demonstrated dramatic improvement in ventricular function, with the ejection fraction having increased to 36%. This case suggests that preoperative assessment of myocardial viability by DE-MRI could help cardiac surgeons to choose the best treatment for patients with ischemic cardiomyopathy.
Similar articles
-
Interaction between two predictors of functional outcome after revascularization in ischemic cardiomyopathy: left ventricular volume and amount of viable myocardium.J Thorac Cardiovasc Surg. 2008 Oct;136(4):930-6. doi: 10.1016/j.jtcvs.2007.11.061. Epub 2008 May 12. J Thorac Cardiovasc Surg. 2008. PMID: 18954632
-
Autologous bone marrow cell transplantation combined with off-pump coronary artery bypass grafting in patients with ischemic cardiomyopathy.Can J Surg. 2008 Aug;51(4):269-75. Can J Surg. 2008. PMID: 18815649 Free PMC article.
-
Use of quantitative analysis of remote myocardial fibrosis with delayed-enhancement magnetic resonance imaging to predict outcomes after surgical ventricular restoration for ischemic cardiomyopathy.J Thorac Cardiovasc Surg. 2008 Dec;136(6):1514-21. doi: 10.1016/j.jtcvs.2008.03.037. Epub 2008 May 19. J Thorac Cardiovasc Surg. 2008. PMID: 19114200
-
Assessment of myocardial viability in ischemic cardiomyopathy.Heart Lung Circ. 2005;14 Suppl 2:S8-13. doi: 10.1016/j.hlc.2005.09.006. Epub 2005 Nov 7. Heart Lung Circ. 2005. PMID: 16352289 Review.
-
Diagnostic and prognostic value of cardiac magnetic resonance imaging in assessing myocardial viability.Top Magn Reson Imaging. 2008 Feb;19(1):15-24. doi: 10.1097/RMR.0B013e31817d550c. Top Magn Reson Imaging. 2008. PMID: 18690157 Review.
Cited by
-
Validation of black blood late gadolinium enhancement (LGE) for evaluation of myocardial infarction in patients with or without pathological Q-wave on electrocardiogram (ECG).Cardiovasc Diagn Ther. 2020 Apr;10(2):124-134. doi: 10.21037/cdt.2019.12.11. Cardiovasc Diagn Ther. 2020. PMID: 32420092 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical